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Summary: A simple and flexible isocratic HPLC procedure was developed for the measurement of catecholamines
and their abundant metabolites (e. g. normetanephrine, metanephrine, 3-methoxy-tyramine, vanillylmandelic acid,
homovanillic acid) and 5-hydroxyindoleacetic acid by ion-pair reversed-phase chromatography on C18 columns,
using a single mobile phase containing both sodium octane sulphonate and diethylamine s ion-pairing reagents.
Introduction
Differential diagnosis of phaeochromatocytoma (1—3),
neuroblastoma (4, 5) and related diseases (6) requires
multiple investigations, among which the determination
of the catecholamines and their metabolites is of primary
importance. Comprehensive biochemical data enable the
clinician to reach an early decisipn and to initiate an
appropriate therapy.
Nowadays, the catecholamines and each group of their
metabolites are generally determined by HPLC using
different sample preparation procedures and different
mobile phases and sep rating condition_s. Parker et al.
(6) described a method for q antifying urinary cat-
echolamines and some of their metabolites under uni-
form HPLC conditions. In this paper we present a newly
developed method using a single mobile phase for an
easy-to^perform determination of urinary epinephrine,
norepinephrine, doparnine, normetanephrine, meta-
nephrine, 3-methoxytyramine, vanillylmandelic acid,
homovanillic acid, and 5-hydroxy-indoleacetic acid.
Materials and Methods
Apparatus and evaluation
The HPLC System used consisted of a Model 2249 pump (Pharma-
cia-LKB, Freiburg, Germany), a Model 2157 autosampler (Pharma-
eia-LKB, Freiburg, Germany), a column oven (5-85°C) and a
Model 460 electrochemical detector (Waters, Eschborn, Germany).
The pump and sampler were PC-controlled by an HPLC-Manager®
from Pharmacia-LKB. Concentrations of detected compounds were
also PC-calculated, using Integration Software, 2600 Version 5.0
(Nelson, Pharmacia-LKB, Freiburg, Germany) which measures the
areas under the detected peaks, relates them to external Standards
and multiplies them with the recovery factor of an internal Stan-
dard, The statistical data were processed by Lotus 1-2-3 for Win-
dows®.
Mobile phase and column
The mobile phase consisted of 4.7 g monochloroacetic acid, 1.8 g
NaOH, 0.51 g Na2EDTA, 0.15 g sodium octane sulphonate, 10.5 g
citric acid monohydrate and 450 μΐ diethylamine made up to one
litre with a water/acetonitrile mixture (92 + 8 or 96 + 4, de-
pending on the column size used). The pH of the Solutions was
adjusted to 3.0 with monochloroacetic acid or NaOH.
Two types of C18 columns were tested: a Waters 5 μιη, 3.9 X 300
mm, C18 Nova Pak (A), and a Pharmacia 3 μτη, 4x125 mm,
SuperPac Spherisorb® ODS2 (B). Most of the analyses were done
with column A, using the 92 + 8 water/acetonitrile mixture s the
mobile phase. Column B was used with the 96 + 4 water/aceto-
nitrile mixture.
Chromatographie conditions
Because of the high oxidation potential ofiso vanillylmandelic acid,
which is used s an internal Standard for the vanillylmandelic acid·
group, the potential used for detecting all the investigated com-
pounds was between 0.75 V and 0.8 V with a Ag/AgCl reference
electrode. The mobile phase flow rate was 0.8 ml/min, and the
column temperature was held at 25 °C.
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Fig. l Typical chromatograms of norepinephrine = I, epineph-
rine = II, dopamine = IV (top), and normetanephrine = V, meta-
nephrine = VI and 3-methoxytyramine = VIII (middle); and vanil-
lylmandelic acid = IX, 5-hydroxy-indoleacetic acid = XI, and ho-
movanillic acid = XII (bottom) under the Chromatographie condi-
tions stated in the text:
(right) chromatograms of Standards (a) and urine patient samples
(b), column A (Waters, C18 Nova Pak® with 5 um, 3.9 X 300
mm size);
(left) chromatograms of Standards, colurnn B (Pharmacia, SuperPac
Spherisorb® ODS2 with 3 μηι, 4 X 125 mm size);
the numbers beside the peaks are the retentioii tiines;
III, VII and X are the internal Standards of dihydroxybenzylan ne,
3-methoxy-4-hydroxy-benzylamine, and iso vanillylmandelic acid.
Procedure
Specimen collection
After centrifugation of an aliquot of 24-h urine, acidified with
10 ml of concentrated HC1, the supernatant was stored at —20 °C
until processing.
Preparation
Extraction of epinephrine, norepinephrine and dopamine
Free catecholamines are extracted from urine using a cation^ex-
change column (Pharmacia-LKB, Freiburg, Germany). To 3 ml of
filtered urine, buffered with 6 ml of Na2EDTA (l g/l H2O), 100 μΐ
of internal Standard (dihydroxybenzylamine, 1.5 mg/1 0.2 mol/1
HC1) were added. This mixture was adjusted to pH 3.0-7.0 with
NaOH and applied to the column. The column was washed once
with 10 ml ammonia (0.05 mol/1), and twice with one column fUl-
ing of water, and the catecholamines were eluated with 6 ml of
mobile phase. An aliquot (30 μΐ) of the eluate was injected into the
HPLC System.
Extraction of metanephrine, normetanephrine and
3-methoxytyramine
This group of catecholamine metabolites was extracted frorn urine
after acidic hydrolysis using a cation-exchange column (Pharma-
cia-LKB, Freiburg, Germany). To 2 ml of filtered, acidified urine
were added 100 μΐ of internal Standard (3-methoxy=4-hydroxy-ben-
zylamine, 2 mg/1 water) in a stoppered tube and the pH was ad-
justed to 0.8—1.0. The solution was incubated for 30 minutes at
90-100 °C to hydrolyse sulphate and glucuronide conjugates, then
cooled to room temperature. The hydrolysed sample was diluted
with 6 ml of buffer (Na2 · EDTA, l g/l water), adjusted to pH 6.0-
10.0 with NaOH, and applied to the cation-exchange column (Phar-
macia-LKB, Freib rg, Gerinany). The column was washed in three
Steps, with 10 ml water, with 3 ml boric acid (40 g/l H2O) and
at least with 5 ml water. Metanephrine, normetanephrine and 3-
niethoxytyramine were eluted from the column with 5 ml of mobile
phase solution, and 50 μΐ of this eluate were injected into the
HPLC System.
Extraction of vanillylmandelic acid, homovanittic acid and
6-hydroxyindoleacetic acid
The acidic metabolites were extracted from urine with an anion-
exchange column (Pharmacia-LKB, Freiburg, Germany). We added
40 μΐ of internal Standard (isov iiillylmandelic acid, 250 mg/1 0.2
mol/1 HC1) to l ml of acidified urine, and diluted this mixture with
4ml of water (HPLC quality). The pH was adjusted to 5.5-6.5
with NaOH, and 1.0 ml of the res lting solution was applied to the
column. The column was washed orice with 3 ml of wash 'buffer I
(ammonia, 0.05 mol/1), and twice with wash buffer Π (boric acid,
40 g/l water). Vanillylmandelic acid, homovanillic acid and 5*
hydroxyindoleacetic acid were eluated with 2 ml of mobile phase
solution. Ten μΐ of the eluate were injected into the HPLC systern.
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Standardizat ion
Three stock Solutions of external Standards were prepared.
Stock solution 1:
2.5 μ§ of norepinephrine, 0.5 μ§ of epinephrine, 10.0 μg of dopam-
ine and 5.0 μg of dihydroxybenzylamine (intemal Standard) were
dissolved in 100 ml 0.2 mol/1 HC1. This stock solution is stable for
min. six months at 4 °C.
Stock solution 2:
5,0 μ§ of normetanephrine, 5.0 μ§ of metanephrine, 5.0 μ§ of 3-
methoxytyramine and 10.0 μ§ of 3-methoxy-4-hydroxy-benzyl-
amine (internal Standard) were dissolved in 100 ml 0.2 mol/1 HC1.
This solution was also stable for at least six months at 4 °C.
Stock solution 3:
50 μ§ of vanillylmandelic acid, 50 μ§ of homovanillic acid, 50 μ%
of 5-hydroxyindoleacetic acid and 50 μ£ of isovanillylmandelic
acid (internal Standard) were dissolved in 100 ml 0.2 mol/1 HCI.
This solution was stable for about one week at 4 °C. Small portions
were kept frozen at 20 °C until they were assayed.
The concentration of the catecholamines and their metabolites in
the unknown samples were calculated by comparison of the peak
areas of the substances to be determined and that of the external
Standard.
Results
Chromatography
Figure l shows repr sentative chromatograms for each
group of catecholamines and metabolites, separated on
column A and column B. Two columns were used to
document the applicability of the chosen mobile phase
to various column types. The retention times for all com-
pounds r nge between 4.0 min for vanillylmandelic acid
and 21.0 min for 3-methoxytyr mine. The constituents
are well separated.
Imprecision
Intra- and inter-assay imprecisions s determined from
analyses of Pharmacia normal and path logical control
urines and from normal urine, are summarized in
tables l arid 2. Intra^assay coefficients of Variation (CV)
were between 1.6% for vanillylmandelic acid and 6.5%
for epinephrine in control urines. In normal urine, CVs
ranged from 2.7% for vanillylmandelic acid to 11.1%
for epinephrine. The inter-assay CVs in» controls were
between 4.1% for vanillylmandelic acid and 7.8% for
epinephrine. In normal urine, the CVs ranged from 6.5%
for vanillylmandelic acid to 14.5% for epinephrine.
Linearity and recovery
Known quantitiesOf e ch investigated component were
added to normal urines to test the linearity and the accu-
racy of the method. The weighed amounts, the original
concentration of the components in the urine and the
Tab. l Intra-assay imprecision of the rnethod in normal, path -
logical control urine and a normal urine pool.
Analyte CV
Control urine (normal)
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-indoleacetic acid
Homovanillic acid
Control urine (path logical)
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-indoleacetic acid
Homovanillic acid
Patient urine
Norepinephrine
Epinephrine
Dopamine
Normatanephrine
Metanephrine
3 -Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-indoleacetic acid
Homovanillic acid
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
μπιοΐ/ΐ
μπκ>1/1
μπιοΐ/ΐ
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
μηιοΐ/ΐ
μπιοΙ/1
μηιοΐ/ΐ
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/I
μηιοΐ/ΐ
μιηοΐ/ΐ
μπιοΐ/l
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
16
20
19
20
20
20
20
20
387.1
128.3
1302
1807
1446
998.2
28.7
58.3
41.1
1176
233.1
2681
7864
3095
2373
84.3
300.6
102.1
457.4
40.9
1144
946.0
450.0
347.5
10.2
54.7
19.6
10.6
8.2
22.2
68.7
23.8
29.3
0.5
1.2
0.9
33.1
9.3
64.0
333.2
117.1
97.5
2.0
8.4
2.7
35.5
4.4
90.8
45.8
20.8
12.0
0.3
1.5
0.4
2.8
6.5
1.7
3.8
1.7
2.9
1.6
2.0
2.2
2.8
4.0
2.4
4.2
3.8
4.1
2.4
2.8
2.7
7.8
11.1
7.9
4.8
4.6
3.4
2.7
2.8
2.1
linear regression data are presented in table 3. The am-
ount measured in each supplemented sample minus the
value of analyte in the urine was compared with the
known amount added. These data are listed in table 4.
Detection limits
The determination of the lower detection limits of the
components is based on the linear dilution of their Stan-
dards.
The detection limits for norepinphrine, epinephrine and
dopamine were 28.0, 21.0 and 124 nmol/l, respectively,
using 30 μΐ injection volume of a Standard dilution. For
normetanephrine, metanephrine and 3-methoxytyramine
the detection limits were 39.0, 36.0 and 128 nmol/1, re-
spectively, using 50 μΐ injection volume of a Standard
solution. The lower detection limits of vanillylmandelic
acid, 5-hydroxy-indoleacetic acid and homovanillic acid
were 3.6, 3.7 and 3.9 μιηοΐ/ΐ, respectively, using Ι Ο μ Ι
injection volume.
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Tab. 2 Inter-assay imprecision of the method in normal, patho-
iogical control urine and a normal urine pool.
Analyte
Control urine (normal)
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3 -Methoxy ty ram ine
Vanillylmandelic acid
5-Hydroxy-indoleacetic acid
Homovanillic acid
Control urine (pathological)
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-ihdoleacetic acid
Homovanillic acid
Patient urine
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-indoleacetic acid
Homovanillic acid
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
umol/1
μτηοΐ/ΐ
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
nmol/1
μτηοΐ/ΐ
μτηοΐ/ΐ
μιηοΐ/l
μτηοΙΛ
μτηοΐ/l
μτηοΐ/ΐ
umol/1
μτηοΐ/ΐ
umol/1
umol/1
μηηοΐ/ΐ
umol/1
η
19
16
20
20
20
20
18
19
19
20
14
20
20
20
20
20
20
20
20
14
20
20
20
18
20
20
20
Χ
426.7
120.0
1381
1648
1501
1053
31.1
56.0
40.5
1196
227.6
2553
9531
3925
2171
86.3
253.2
103.2
427.3
30.0
1823
2423
354.0
1025
10.4
50.4
19.5
s
24.8
10.9
75.8
32.2
39.6
36.5
2.0
4.5
2.2
68.6
18.0
173.7
333.3
131.8
81.3
3.5
14.2
4.9
22.5
4.4
62.1
63.3
21.3
35.9
0.6
2.2
0.5
CV
(%)
5.8
9.1
5.5
2.0
2.6
3.5
6.5
8.1
5.4
5.7
7.8
6.8
3.5
3.4
3.7
4.1
5.6
5.0
5.2
14.5
3.4
2.6
6.1
8.6
5.6
4.3
2.6
Tab. 4 Analytical recovery and accuracy.
Analyte
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic acid
5-Hydroxy-indoleacetic
acid
Homovanillic acid
Weighed
amount
added to
urine
[μπιοΐ/ΐ]
: r
5.7
1 7
 . /
0.24
4.4
2.2
0.44
5.3
2.65
1.85
10.9
5.45
f\ CC0.55
7.6
5.1
1.3
9.0
6.0
1.5
459
306
92
407
110
39•js
330
1!32
83
Recovered
[μιηοΐ/ΐ]
6.1
1 O1 .7
0.26
4.31
2.12
0.38
5.9
2.95
1.98
11.07
6.44
Λ C A0.54
8.1
5.6
1,4
9.5
6.5
1.5
512
335
103
411
110
41
384
136
84
Recovery
[%]
107
113
  J
111
98
96
89
111
111
107
102
118
c\c\99
107
112
108
106
109
100
103
110
112
99
100
94
107
103
101
Tab. 3 The linearity of the method and recovery.
Analyte
Norepinephrine
Epinephrine
Dopamine
Normetanephrine
Metanephrine
3-Methoxytyramine
Vanillylmandelic aicd
5-Hydroxy-indoleacetic acid
Homovanillic acid
Linear
regression
equations
y = 1.43x + 0.21
y = 1.06x - 0.01
y = 1.19x + 1.03
y = 0.99x H- 1.04
y = 1.16x + 0.50
y = 0.91x + 0.57
y = 1.15x + 7.47
y = 1.72x -43.83
y = 1.45x - 12.83
r
0.999
0.999
0.999
0.990
0.995
0.992
0.998
0.936
0.989
Concen-
tration
in native
urine
[μηιοΜ]
0.40
0.15
1.11
0.71
0.49
0.34
12.6
24.8
15.4
Weighed
amount
added to
urine
[μιηο1/1]
23.62
22.00
26.49
13.63
12.56
15.03
609
548
660
Total
content
[μηιοΐ/ΐ]
24.02
22.15
27.60
14.34
13.05
15.37
621.6
572.8
675.4
Detected
content
[μηίοΐ/ΐ]
23.64
21.83
26.13
13.65
12.68
14,95
605
633
659
Recov-
ery
[%]
98.4
98.6
94.7
95.2
97.2
97.3
97.3
110.5
97.6
Discussion
The catecholamines and their methoxy derivatives,
metanephrine, normetanephrine and 3-methoxy-tyram-
ine, are basic compounds, whereas Vanillylmandelic
acid, homovanillic acid and 5-hydroxyindoleacetic acid
are acidic components. Thus, they can be separated by
cation- and anion-exchange chrornatography, respect-
ively, or by ion-pair reversed-phase chrornatography us-
ing different mobile phase. Because of the diversity of
eatecholamine-prod cing t mpurs, a complete analysis
of the catecholamines and their methoxy and acidic
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metabolites is clinically indicated in many cases. Uni-
form analytical conditions contribute to a better practica-
bility of the method in the clinical chemical laboratory
and to a reduction of analysis time and costs. As an
approach to this analytical goal we suggest a single mo-
bile phase for the HPLC Separation of all three groups
of components. We used a mixture of sodium octane
sulphonate and diethylamine in the mobile phase in or-
der to form ion-pairs for both amines and acidic com-
pounds. Peak discrimination is also enhanced by optim-
ization of the pH of the mobile phase. Good results are
obtained with pH 3.0 (7, 8). Uniformity is also achieved
in the sample preparation procedure by using the mobile
phase to elute all three classes of analytes from the so-
lid-phase extraction cartridges. Using mobile phase in
the sample work-up procedure also reduces interferences
in the analysis.
The mobile phase can be recycled and one column has
been used for more than 2000 analyses. In contrast to
the method described by Parker et al. (6), our method
also determines 3-methoxy-tyramine and homovanillic
acid. In addition, we were able vary the size of the col-
umn according to the ratio of acetonitrile/water used in
the mobile phase.
The method described is simple, practicable and reliable,
and suitable for routine determinations of the cat-
echolamines and all of their clinically relevant metab-
olites in the diagnosis of catecholamine-producing tu-
mours.
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